Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Neoadjuvant Pemetrexed plus Cisplatin Followed by Surgery and Radiation in Pleural Mesothelioma
2004-002537-39Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed and cisplatin in pleural mesothelioma, sponsored by Eli Lilly and Company. Started Feb 2005; status: completed.
02
Drugs
pemetrexedcisplatin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2004-002537-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002537-39.